| 貨號 | 規格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|
| S80510-1mg | 98% | ￥200.00 | 6 | - | - | - |
|
| S80510-2mg | 98% | ￥360.00 | 7 | - | - | - |
|
| S80510-5mg | 98% | ￥520.00 | 6 | - | - | - |
|
| S80510-10mg | 98% | ￥600.00 | 8 | - | - | - |
|
| S80510-25mg | 98% | ￥750.00 | 4 | - | - | - |
|
| S80510-50mg | 98% | ￥950.00 | 貨期：2-3天 | - | - | - |
|
| S80510-100mg | 98% | ￥1570.00 | 貨期：2-3天 | - | - | - |
|
PD168393 is a potent, selective and cell-permeable inhibitor of EGFR tyrosine kinase and ErbB2. PD168393 irreversiblely inactivates EGF receptor ( IC50=0.7 nM) and is inactive against insulin receptor, PDGFR, FGFR and PKC
| 產品描述： | PD168393 is a potent, selective and cell-permeable inhibitor of EGFR tyrosine kinase and ErbB2. PD168393 irreversiblely inactivates EGF receptor ( IC50=0.7 nM) and is inactive against insulin receptor, PDGFR, FGFR and PKC | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | EGFR:0.7 nM (IC50);Apoptosis;EGFR;FGFR;IGF-1R;PDGFR;PKC;Autophagy | ||||||||||||||||||||
| 體內研究： | PD168393 (intraperitoneal injection; 58 mg/kg; once daily; days 10-14, 17-21, and 24-28) is effective in vivo, and produces tumor growth inhibition of 115% after 15 days’ treatment in human epidermoid carcinoma xenografts in mice | ||||||||||||||||||||
| 參考文獻： | 1. D W Fry, et al. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7. | ||||||||||||||||||||
| 溶解性： | DMSO : ≥ 30 mg/mL (81.25 mM) | ||||||||||||||||||||
| 保存條件： | RT | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京